Skip to content

Mobile Health for Chronic Obstructive Pulmonary Disease (COPD).

Evaluation of an innovative mobile health program for the self-management of chronic obstructive pulmonary disease (MH-COPD).

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618001091291
Acronym
MH-COPD
Enrollment
9
Registered
2018-06-29
Start date
2019-06-06
Completion date
2021-03-15
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

*The aim of this study is to examine whether an innovative mobile health (mHealth)-enabled care program (MH-COPD) will improve patient self-management and relevant health outcomes. *We expect that the MH-COPD program would increase the self-management of COPD patients and consequently improve health outcomes.

Interventions

*The intervention is a mobile health platform (application, ‘app’) provided to participants through the Google Play store for their own personal device or provided through an approved mobile device supplied by the researchers. *Participants will receive 10 educational videos, available at the Lung Foundation Australia website, over the first 5 weeks that range from 6-12 minutes and cover ten topics: 1) Managing your lung disease, 2) How do your lungs work? 3) Managing your breathlessness, 4) Ma

*The intervention is a mobile health platform (application, ‘app’) provided to participants through the Google Play store for their own personal device or provided through an approved mobile device supplied by the researchers. *Participants will receive 10 educational videos, available at the Lung Foundation Australia website, over the first 5 weeks that range from 6-12 minutes and cover ten topics: 1) Managing your lung disease, 2) How do your lungs work? 3) Managing your breathlessness, 4) Managing treatment options, 5) Questions you can ask your health professional, 6) Who is your healthcare team? 7) Managing your fatigue and energy conservation, 8) Tips for looking after yourself and your condition, 9) Benefits of exercise programs and ongoing support, and 10) Supportive care and end-of-life issues. *Participants will have access to pre-loaded videos on learning to use inhalers properly, approved by the Lung Foundation Australia. *Participants will have access to a daily symptom diary to record daily symptoms and exacerbations. *Participants will have access to an electronic physical activity plan, involving a built-in step counter in the app, which automatically sets incremental goals of increased step counts each week for the first 4 weeks. *Participants will have access to an electronic version of The Prince Charles Hospital's COPD action plan that will guide symptom and exacerbation control through medications that participants have access to. *Participants who smoke will have access to an electronic version of the smoking cessation plan that records and aims to reduce the number of cigarettes smoked down to zero after 6 weeks. This is done by gradually reducing the daily smoking goals, by advising the use of smoking cessation plan which includes medications, and through automated, motivational messages (simple encouragement) sent through the app to the mobile phone. *Participants in the intervention group will be requested to use the app at least once each day. *All the data entries of the participants recorded via the app, such as symptoms, the action plan, and cigarettes, will be automatically uploaded to the online portal and analysed by research staff to assess the patient adherence. If a participant does not adhere to program for two days, alerts will be generated, and automated motivational messages will be sent to the participant via app notifications. The research staff will review the alerts and accordingly contact the participant to troubleshoot the non-adherence. *Participants will be provided a 60-minute, face-to-face training session in using the mobile health application (‘app’) by research staff.

Sponsors

The Prince Charles Hospital Foundation
Lead SponsorCharities/Societies/Foundations

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

*Diagnosis of COPD defined according to the international GOLD guidelines *Chronic airflow limitation that is not fully reversible (post-bronchodilator FEV1/FVC <70% and FEV1 <80% predicted) *Current or former smokers with a smoking history of >10 pack-years

Exclusion criteria

*Women who are pregnant *Intellectual or mental impairment *Other comorbid lung diseases including asthma, active lung cancer, interstitial lung disease, and severe bronchiectasis *Limitations to the use of mobile technology: non-corrective vision, hearing, cognitive or dexterity impairments that limit the use of technology

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 21, 2026